Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Molecular epidemiology reveals the role of war in the spread of HIV in Ukraine.

Vasylyeva TI, Liulchuk M, Friedman SR, Sazonova I, Faria NR, Katzourakis A, Babii N, Scherbinska A, Thézé J, Pybus OG, Smyrnov P, Mbisa JL, Paraskevis D, Hatzakis A, Magiorkinis G.

Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1051-1056. doi: 10.1073/pnas.1701447115. Epub 2018 Jan 16.

2.

Embolic Stroke Diagnosed by Elevated D-Dimer in a Patient With Negative TEE for Cardioembolic Source.

Sazonova IY, Pondicherry-Harish R, Kadle N, Sharma GK, Figueroa RE, Robinson VJ.

J Investig Med High Impact Case Rep. 2014 Dec 10;2(4):2324709614560907. doi: 10.1177/2324709614560907. eCollection 2014 Oct-Dec.

3.

Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke.

Buckley KM, Hess DL, Sazonova IY, Periyasamy-Thandavan S, Barrett JR, Kirks R, Grace H, Kondrikova G, Johnson MH, Hess DC, Schoenlein PV, Hoda MN, Hill WD.

Exp Transl Stroke Med. 2014 Jun 21;6:8. doi: 10.1186/2040-7378-6-8. eCollection 2014.

4.

[First experience of application of assist circulation device using biventricular type "excor"].

Gordeev ML, Karpenko MA, Nikolaev GV, Gnevashev AS, Malaia EIa, Naĭmushin AV, Rubinchik VE, Sukhova IV, Mitrofanova LB, Somin MIu, Sazonova IuV, Stepanov SS, Fedotov PA.

Vestn Khir Im I I Grek. 2013;172(5):71-6. Russian.

PMID:
24640753
5.

[Pages of the past: hospitalization and regime for patients with myocardial infarction].

Syrkin AL, Sazonova IuS.

Klin Med (Mosk). 2012;90(9):79-80. Russian. No abstract available.

PMID:
23214022
6.

Detection and treatment of intravascular thrombi with magnetofluorescent nanoparticles.

Erdem SS, Sazonova IY, Hara T, Jaffer FA, McCarthy JR.

Methods Enzymol. 2012;508:191-209. doi: 10.1016/B978-0-12-391860-4.00010-0.

PMID:
22449927
7.

Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy.

McCarthy JR, Sazonova IY, Erdem SS, Hara T, Thompson BD, Patel P, Botnaru I, Lin CP, Reed GL, Weissleder R, Jaffer FA.

Nanomedicine (Lond). 2012 Jul;7(7):1017-28. doi: 10.2217/nnm.11.179. Epub 2012 Feb 21.

8.

[The first experience with heart transplantation in the Federal Center of the Heart, Blood and Endocrinology named after V. A. Almazov].

Shliakhto EV, Gordeev ML, Karpenko MA, Nikolaev GV, Gnevashev AS, Malaia EIa, Naĭmushin AV, Rubinchik VE, Bautin AE, Sitnikova MIu, Sukhova IV, Kiseleva MG, Mitrofanova LB, Sazonova IuV, Stepanov SS, Zverev DA, Moiseeva OM.

Vestn Khir Im I I Grek. 2011;170(4):10-5. Russian.

PMID:
22191249
9.

Sex-independent neuroprotection with minocycline after experimental thromboembolic stroke.

Hoda MN, Li W, Ahmad A, Ogbi S, Zemskova MA, Johnson MH, Ergul A, Hill WD, Hess DC, Sazonova IY.

Exp Transl Stroke Med. 2011 Dec 16;3(1):16. doi: 10.1186/2040-7378-3-16.

10.

Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential.

Machado LS, Sazonova IY, Kozak A, Wiley DC, El-Remessy AB, Ergul A, Hess DC, Waller JL, Fagan SC.

Stroke. 2009 Sep;40(9):3028-33. doi: 10.1161/STROKEAHA.109.556852. Epub 2009 Jul 23.

11.

Reprogrammed streptokinases develop fibrin-targeting and dissolve blood clots with more potency than tissue plasminogen activator.

Sazonova IY, McNamee RA, Houng AK, King SM, Hedstrom L, Reed GL.

J Thromb Haemost. 2009 Aug;7(8):1321-8. doi: 10.1111/j.1538-7836.2009.03491.x. Epub 2009 Jun 30.

12.

Fibrinolysis is amplified by converting alpha-antiplasmin from a plasmin inhibitor to a substrate.

Sazonova IY, Thomas BM, Gladysheva IP, Houng AK, Reed GL.

J Thromb Haemost. 2007 Oct;5(10):2087-94.

13.

Regulation of nonproteolytic active site formation in plasminogen.

Gladysheva IP, Sazonova IY, Houng A, Hedstrom L, Reed GL.

Biochemistry. 2007 Jul 31;46(30):8879-87. Epub 2007 Jul 7.

PMID:
17616171
14.

[Ranisan, 75 mg in the treatment of patients with the functional dyspepsia syndrome].

Manushkin ON, Maslovskiĭ LV, Shuleshova AG, Sazonova II, Anikina NIu.

Eksp Klin Gastroenterol. 2005;(5):53-5. Russian. No abstract available.

PMID:
16518916
15.

[Isolation, purification, and identification of virulence protein VirE2 from Agrobacterium tumefaciens].

Volokhina IV, Sazonova IA, Velikov VA, Chumakov MI.

Mikrobiologiia. 2005 Jan-Feb;74(1):92-8. Russian.

PMID:
15835784
16.

Isolation, purification, and identification of the virulence protein VirE2 from Agrobacterium tumefaciens.

Volokhina I, Sazonova I, Velikov V, Chumakov M.

Microbiol Res. 2005;160(1):67-73.

17.

alpha Domain deletion converts streptokinase into a fibrin-dependent plasminogen activator through mechanisms akin to staphylokinase and tissue plasminogen activator.

Sazonova IY, Robinson BR, Gladysheva IP, Castellino FJ, Reed GL.

J Biol Chem. 2004 Jun 11;279(24):24994-5001. Epub 2004 Apr 6.

18.

Coevolutionary patterns in plasminogen activation.

Gladysheva IP, Turner RB, Sazonova IY, Liu L, Reed GL.

Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9168-72. Epub 2003 Jul 23.

19.

Structural elements that govern the substrate specificity of the clot-dissolving enzyme plasmin.

Turner RB, Liu L, Sazonova IY, Reed GL.

J Biol Chem. 2002 Sep 6;277(36):33068-74. Epub 2002 Jun 21.

20.

Chimerism reveals a role for the streptokinase Beta -domain in nonproteolytic active site formation, substrate, and inhibitor interactions.

Gladysheva IP, Sazonova IY, Chowdhry SA, Liu L, Turner RB, Reed GL.

J Biol Chem. 2002 Jul 26;277(30):26846-51. Epub 2002 May 16.

21.

[DNA from various tissues of the Far Eastern larch and its applicability for RAPD assay].

Sazonova IIu, Kozyrenko MM, Artiukova EV, Reunova GD, Zhuravlev IuN.

Izv Akad Nauk Ser Biol. 2001 Mar-Apr;(2):243-8. Russian.

PMID:
11357392
22.

The mechanism of a bacterial plasminogen activator intermediate between streptokinase and staphylokinase.

Sazonova IY, Houng AK, Chowdhry SA, Robinson BR, Hedstrom L, Reed GL.

J Biol Chem. 2001 Apr 20;276(16):12609-13. Epub 2001 Jan 18.

23.

Leucine 42 in the fibronectin motif of streptokinase plays a critical role in fibrin-independent plasminogen activation.

Liu L, Sazonova IY, Turner RB, Chowdhry SA, Tsai J, Houng AK, Reed GL.

J Biol Chem. 2000 Dec 1;275(48):37686-91.

24.

Kinetic properties of the activator complexes plasmin--staphylokinase and plasmin(ogen)--streptokinase in vitro.

Sazonova IY, Aisina RB, Muhametova LI, Varfolomeyev SD.

Biochemistry (Mosc). 1999 Jan;64(1):66-74.

PMID:
9986915
25.

[Inactivation and stabilization of urokinase fibrinolytic activity in vitro].

Aĭsina RB, Mukhametova LI, Sazonova IIu, Varfolomeev SD.

Bioorg Khim. 1998 Jul;24(7):544-8. Russian.

PMID:
9749317
26.

[Bacteriolytic properties of the blood serum of rheumatism patients].

Sazonova IM.

Lab Delo. 1980;(6):362-5. Russian. No abstract available.

PMID:
6156314
27.

[Evaluation of the bacteriolytic activity of blood serum].

Sazonova IM.

Lab Delo. 1977;(7):418-20. Russian. No abstract available.

PMID:
71379
28.

Substrate and inhibitor specificity of cholinesterases from certain insects.

Brick IL, Brestkin AP, Mandelshtam JE, Sazonova IN.

Environ Qual Saf Suppl. 1975;3:539-43. No abstract available.

PMID:
1063677
29.

[Cholinesterase of the pea aphid Acyrthosiphon pisi Kalt].

Sazonova IN, Novozhilov KV, Brik IL, Andreeva NA.

Biokhimiia. 1972 May-Jun;37(3):579-84. Russian. No abstract available.

PMID:
5045105

Supplemental Content

Loading ...
Support Center